TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) revenue & profit
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): revenue $17.3B, net income $1.4B in 2025; latest quarter -0.8% year over year. From SEC filings.
$17.3BRevenue 2025
TickerTEVA (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$17.3B
Net income 2025$1.4B
Net margin8.2%
Annual revenue growth+4.3%
Latest quarter (2026 Q2) · Revenue$4.1B
vs. same quarter last year-0.8%
Latest quarter · Net income-$576M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $14.9B | -$2.4B | |
| 2023 | $15.8B | -$559M | |
| 2024 | $16.5B | -$1.6B | |
| 2025 | $17.3B | $1.4B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.